説明
Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.
More Figures from This Paper
Figure 2
Illustration of Saccharomyces boulardii CNCM I-745 mechanisms of action in the intestinal lumen, showing direct antimicrobial effects and pathogen binding at the gut epithelial surface.
diagram
Figure 3
Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement.
diagram
Figure 4
Schematic depicting how S. boulardii CNCM I-745 modulates intestinal epithelial barrier function, including tight junction protein preservation and mucus secretion enhancement.
diagram
Figure 5
Diagram of S. boulardii's immunomodulatory actions in the gut, illustrating effects on secretory IgA production, anti-inflammatory cytokine release, and immune cell regulation.
diagram
Figure 6
Diagram of S. boulardii's immunomodulatory actions in the gut, illustrating effects on secretory IgA production, anti-inflammatory cytokine release, and immune cell regulation.
diagram
Figure 8
Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.
diagramFigure 7
DiagramSource Paper
Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against intestinal infections.Cite This Figure
 > Source: Dorota Czerucka et al. "Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against int." *World journal of gastroenterology*, 2019. PMID: [31143070](https://pubmed.ncbi.nlm.nih.gov/31143070/)
<figure> <img src="https://pdfs.citedhealth.com/figures/31143070/200.png" alt="Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms." /> <figcaption>Figure 7. Evidence summary for S. boulardii CNCM I-745 efficacy against specific intestinal pathogens including Clostridium difficile, showing toxin neutralization and receptor binding inhibition mechanisms.<br> Source: Dorota Czerucka et al. "Diversity of Saccharomyces boulardii CNCM I-745 mechanisms of action against int." <em>World journal of gastroenterology</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31143070/">31143070</a></figcaption> </figure>